CHS under investigation over EHR adoption

Community Health Systems (CHS) is under investigation over its adoption of electronic health records (EHRs) and adherence to a federal program to fund the technology. The investigation was revealed in the company’s most recent quarterly earnings filings with the Securities and Exchange Commission. CHS is one of the nation’s largest hospital systems, with 118 hospitals in 20 states.

Under the government’s meaningful use program, healthcare providers were given incentive payments to adopt EHR technology. The government has distributed more than $38 billion through the program since 2011, and hospitals that fail to demonstrate meaningful use of certified EHR technology are subject to payment adjustments.

CHS is currently facing a civil investigative demand related to its EHR adoption and the meaningful use program. The company stated it does not expect the investigation–and other pending legal proceedings–to have a financial impact but conceded there could be monetary penalties down the road. CHS has received more than $865 million in EHR incentive payments between 2011 and 2017, FierceHealthcare reported.

The revelation underscores heightened scrutiny around the program and EHR adoption.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup